Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Oppenheimer has recently initiated Inari Medical Inc (NARI) stock to Outperform rating, as announced on December 17, 2024, according to Finviz. Earlier, on September 18, 2024, Stifel had initiated the ...

This page features the latest news about the Inari Med stock. Inari medical director William Hoffman sells $12.1 million in stock William Hoffman, a director at Inari Medical (TASE:PMCN), Inc ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...

In this article, we are going to take a look at where Inari Medical Inc. (NASDAQ:NARI) stands against the other stocks. Ten companies finished stronger this week, outpacing the broader market ...

We recently published an article titled These 10 Firms Led This Week's Rally. In this article, we are going to take a look at where Inari Medical Inc. (NASDAQ:NARI) stands against the other stocks.

In other Inari Medical news, Director William Hoffman sold 200,000 shares of the firm’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $60 ...